Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 34,204 | 13 | 18 | 29 | 638 |
| Gross Profit | 34,204 | 13 | 18 | 29 | 638 |
| Operating Expenses | 21,696 | 20,680 | 21,895 | 22,141 | 25,484 |
| Operating Income | 12,508 | -20,667 | -21,877 | -22,112 | -24,846 |
| Interest Expense | 348 | 362 | 358 | 354 | 392 |
| Other Income | 7,088 | -743 | -1,285 | 1,901 | 7,493 |
| Pre-tax Income | 19,248 | -21,772 | -23,520 | -20,565 | -17,745 |
| Net Income Continuous | 19,248 | -21,772 | -23,520 | -20,565 | -17,745 |
| Net Income | $20,133 | $-21,772 | $-23,520 | $-20,565 | $-17,745 |
| EPS Basic Total Ops | 2.62 | -1.84 | -2.13 | -2.21 | -3.10 |
| EPS Basic Continuous Ops | 2.55 | -1.84 | -2.13 | -2.21 | -3.09 |
| EPS Diluted Total Ops | 2.62 | -1.84 | -2.13 | -2.21 | -3.08 |
| EPS Diluted Continuous Ops | 2.55 | -1.84 | -2.13 | -2.21 | -3.07 |
| EPS Diluted Before Non-Recurring Items | 0.36 | -1.84 | -2.13 | -2.21 | -3.20 |
| EBITDA(a) | $13,186 | $-20,224 | $-21,359 | $-21,680 | $-24,278 |